Replies to post #160463 on Cytodyn Inc (CYDY)

[MelsDollars]

I doubt the entire company is up for sale. It's just too valuable with so many potential indications. However, I wouldn't be surprised if a licensing or partnership deal was structured for one indication, covid-19 in the U.S. for example. That would bring an infusion of cash and allow them to ramp up future trials. My preference, of course, would be Cytodyn making their own way, but I'm not so naive to believe that it wouldn't help with the FDA if one of their BP friends was involved.

[bwolfy2002]

Overall Patient Experience

Very Positive
(4/5)
14 Reviews Total|10 Reviews Within Last 12 Months

Looks pretty good to me at a cursory glance (which I can do as well by the way).

https://health.usnews.com/doctors/nicholas-agresti-682936

[bwolfy2002]

“Medical School & Residency

University of Florida College of Medicine at Jacksonville
Fellowship, Gastroenterology

University of Miami School of Medicine
Fellowship, Hepatology

Norwalk Hospital - Yale University
Residency, Internal Medicine

American University of the Caribbean School of Medicine
Medical School”


Residency at Yale. Yeah I’m pretty sure his pedigree is just fine.